Voiding Diary — Separating Day and Night Urine Output
A short placeholder: diaries capture volume and timing of every void.
- 3 days: Diary duration (standard clinical practice)
- Time+vol: Data points (per void event)
- 22:00–06:00: Night window (typical sleep period)
- 06:00–22:00: Day window (waking hours)
Why diaries matter
Short placeholder: diaries reveal true day/night split objectively.
Calculating the Nocturnal Polyuria Index (NPi)
Short placeholder: NPi flags excess nighttime urine production.
- >33%: NPi threshold (younger adults)
- >20–33%: Elderly threshold (age-adjusted cutoff)
- NUV/24hUV: Formula (nighttime / total volume)
- ~80%: Prevalence (of nocturia cases)
Interpreting NPi
Short placeholder: higher NPi points toward polyuria-driven nocturia.
Evening Fluid Restriction Strategy
Short placeholder: reducing evening intake cuts nighttime volume.
- 2–4h: Cutoff time (before bedtime)
- ~10–20%: Volume reduction (typical effect)
- Avoid: Caffeine/alcohol (evening diuretic triggers)
- Moderate: Adherence (behavioral challenge)
Behavioral first line
Short placeholder: simplest, lowest-risk first intervention step.
Desmopressin — Antidiuretic Hormone Analog Therapy
Short placeholder: desmopressin lowers nighttime urine production.
- V2 agonist: Mechanism (renal water reabsorption)
- ~1–1.5x: Void reduction (fewer nighttime voids)
- Hyponatremia: Key risk (monitor sodium levels)
- Sodium: Monitoring (especially in elderly)
Dosing caution
Short placeholder: lowest effective dose with sodium monitoring.
Assessing Sleep Quality Impact of Nocturia
Short placeholder: fewer voids improve sleep continuity and quality.
- High: Sleep fragmentation (with ≥2 voids/night)
- Reduced: Quality of life (with untreated nocturia)
- Increased: Daytime fatigue (from disrupted sleep)
- ≤1 void: Treatment goal (per night target)
Outcome tracking
Short placeholder: reassess diary and sleep quality after treatment.
Short placeholder: combined therapy often best restores sleep.